Evaluation of Borrelia burgdorferi sensu lato seroprevalencein the province of Bolu, Turkey
Evaluation of Borrelia burgdorferi sensu lato seroprevalencein the province of Bolu, Turkey
Background/aim: The aim of the present study was to determine the seroprevalence of Borrelia burgdorferi sensu lato in the city center and the province of Bolu, Turkey. Materials and methods: A stratified sampling method was used to determine the study population. A total of 196 blood samples were collected. A questionnaire was completed by each participant in the study. ELISA was performed and positive serologic results were confirmed using western blotting. Data were analyzed statistically using the chi-square test. Results: Seropositivity rates of B. burgdorferi IgM and IgG were determined as 14.8% (29/196) and 13.7% (27/196) respectively by ELISA. A total of nine serum samples (4.6%) were found positive for IgG, and seven samples (3.8%) were positive for IgM according to western blotting. Seropositivity rates were found to be higher in people living in rural areas (11.1%), in women (8.3%), in people who were illiterate (10.0%), in people engaged in agriculture (10.8%), and in the age group of 40 60 years (10.0%). No statistically significant difference was found between seropositivity rates and survey data. Conclusion: The seroprevalence of Lyme disease was determined in our region. Detection of endemic regions of Lyme disease with determination of seropositivity rates will increase the awareness among clinicians about this disease.
___
- 1. Bulut C, Tufan ZK, Altun Ş, Altınel E, Kınıklı S, Demiröz AP. An overlooked disease of tick bites: Lyme disease. Mikrobiyol Bul 2009; 43: 487-492 (in Turkish with English abstract).
- 2. Kaya AD, Parlak AH, Öztürk CE, Behcet M. Seroprevalence of Borrelia burgdorferi infection among forestry workers and farmers in Düzce, north-western Turkey. New Microbiol 2008; 31: 203-209.
- 3. Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T. Lyme disease: review. Arch Med Sci 2012; 8: 978-982.
- 4. Shapiro ED, Gerber MA. Lyme disease. Clin Infect Dis 2000; 31: 533-542.
- 5. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme diseaseUnited States, 1992-2006. MMWR Surveill Summ 2008; 57: 1-9.
- 6. Hubálek Z. Epidemiology of Lyme borreliosis. Curr Probl Dermatol 2009; 37: 31-50.
- 7. Mutlu G, Gültekin M, Ergin Ç, Sayın F, Kurşun EA. Investigation of Borrelia burgdorferi antibodies and vectors in Antalya region. Mikrobiyol Bul 1995; 29: 1-6 (in Turkish with English abstract).
- 8. Çelik AF, Turgut H, Çetin CB, Yalçın AN, Kaleli İ. Denizli yöresinde Borrelia burgdorferi antikor sıklığının araştırılması. İnfeksiyon Dergisi 2001; 15: 439-441 (in Turkish).
- 9. Birengel S, Boşça A, Kurt H, Tekeli E. Sağlıklı bireylerde ve bazı hasta gruplarında lyme seropozitifliği. Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi (FLORA) 1999; 4: 51-57 (in Turkish).
- 10. Bennet L, Sternberg L, Berglund J. Effect of gender on clinical and epidemiologic features of Lyme borreliosis. Vector Borne Zoon Dis 2007; 7: 34-41.
- 11. Aslan Başbulut E, Gözalan A, Sönmez C, Cöplü N, Körhasan B, Esen B, Akın L, Ertek M. Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey. Mikrobiyol Bul 2012; 46: 247-256 (in Turkish with English abstract).
- 12. Robert Koch-Institut. Neuerkrankungen an Lyme-Borreliose im Jahr 2004. Epidemiol Bull 2005; 32: 285-288 (in German).
- 13. Lledó L, Gegúndez MI, Saz JV, Beltrán M. Screening of the prevalence of antibodies to Borrelia burgdorferi in Madrid province, Spain. Eur J Epidemiol 2004; 19: 471-472.
- 14. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, Maraspin V, Aguero-Rosenfeld ME, Varde S, Lotric-Furlan S et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999; 130: 32-36.
- 15. Wojciechowska-Koszko I, Mączyńska I, Szych Z, Giedrys-Kalemba S. Serodiagnosis of borreliosis: indirect immunofluorescence assay, enzyme-linked immunosorbent assay and immunoblotting. Arch Immunol Ther Exp (Warsz) 2011; 59: 69-77.
- 16. Aguero-Rosenfeld ME. Lyme disease: laboratory issues. Infect Dis Clin North 2008; 22: 301313.
- 17. Chmielewska-Badora J, Cisak E, Wójcik-Fatla A, Zwolinski J, Buczek A, Dutkiewicz J. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis. Ann Agric Environ Med 2006; 13: 307- 311.
- 18. Guner ES, Hashimoto N, Takada N, Kaneda K, Imai Y, Masuzawa T. First isolation and characterization of Borrelia burgdorferi sensu lato strains from Ixodes ricinus ticks in Turkey. J Med Microbiol 2003; 52: 807-813.
- 19. Cisak E, Chmielewska-Badora J, Zwoliński J, Wojcik-Fatla A, Zajac V, Skórska C, Dutkiewicz J. Study on Lyme borreliosis focus in the Lublin region (eastern Poland). Ann Agric Environ Med 2008; 15: 327-332.
- 20. Hristea A, Hristescu S, Ciufecu C, Vasile A. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol 2001; 17: 891-896.
- 21. Tomao P, Ciceroni L, DOvidio MC, De Rosa M, Vonesch N, Lavicoli S, Signorini S, Ciarrocchi S, Ciufolini MG, Fiorentini C et al. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy. Eur J Clin Microbiol Infect Dis 2005; 24: 457-463.
- 22. Chmielewski T, Tylewska-Wierzbanowska S. Prevalence of Borrelia burgdorferi antibodies in healthy population in Poland. Przegl Epidemiol 2002; 56: 33-38.
- 23. Demirci M, Yorgancıgil B, Tahan V, Arda M. Lyme disease seropositivity in people with history of tick bite in the Isparta region of Turkey. İnfeksiyon Derg 2001; 15: 17-20.
- 24. Aydın K, Köksal İ, Çaylan R, Karagüzel A, Volkan S, Kaygusuz S, Öksüz R, Kostakoğlu U. Trabzon yöresinde lyme seropozitifliği. İnfeksiyon Derg 2001; 15: 141-144 (in Turkish).
- 25. Bozkurt H, Çiftçi İH, Güdücüoğlu H, Berktaş M, Körkoca H, Akdeniz H. Investigation of Borrelia Burgdorferi seroprevalence in Van region of Turkey. Turk J Immunol 2008; 13: 5-9.